American College of Gastroenterology (ACG) Annual Meeting

Virtual Event

Healix is a proud participant of collaborative research with GI Alliance at the 2020 American College of Gastroenterology (ACG) Annual Meeting. Visit the poster presentation at this year’s virtual conference October 23 – 28, 2020.

Real-World Experience with Vedolizumab as First-Line Therapy for the Treatment of Ulcerative Colitis

Timothy E. Ritter, MD1; Samantha A. Mehta, PharmD2; Lucinda J. Van Anglen, PharmD2
1GI Alliance, Southlake, TX, 2 Healix Infusion Therapy, LLC, Sugar Land, TX

Learn more about our outcomes research and how Healix can help you establish an office infusion center or outsource the management of an existing operation by contacting us today!


View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.